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ABSTRACT
Introduction: Few studies have analyzed the
importance of socio-demographic variables on
the perception of health-related quality of life
(HRQoL) in patients with multiple sclerosis
(MS).
Methods: The sample was composed of 150
patients with MS. Statistical analysis was
performed using Mann–Whitney U and Kruskal–
Wallis H non-parametric tests comparing socio-
demographic items with HRQoL.
Results: We found statistically significant
differences between age, education levels,
employment status, disability and all
dimensions of HRQoL.
Discussion: This study contributes to a more
systematic knowledge about the relationship
between social characteristics and HRQoL,
which is important to improve the planning
of health care in MS patients.
Conclusion: We found that younger patients,
those with higher education level, those who
were employed, and with lower disease
progression and lower disability, had better
HRQoL.
Keywords: Multiple sclerosis; Neurology;
Quality of life; Social characteristics
INTRODUCTION
Multiple sclerosis (MS) is a chronic, inflammatory,
immune-mediated demyelinating disease of the
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centralnervous system (CNS).Thoughthecauseof
MS is still unknown, there is a growing body of
evidencedemonstrating its multifactorialoriginas
a result of the interaction between environmental
aspects in genetically susceptible individuals,
triggering the immunological changes
underlying the disease process [1, 2]. MS usually
starts between 20 and 40 years of age, is more
common among women (female:male ratio
&2:1), and may progress via different
evolutionary patterns. In most cases, it develops
in a relapsing-remitting (RR) form, with clearly
defined relapses separated by complete or partial
recovery; some RR patients later present with a
secondary progressive (SP) MS type accompanied
by disease progression with or without further
relapses [1]. A few patients have progressive
evolution of their disease from the beginning
without experiencing relapses; these patients have
primary progressive (PP) MS or rarely, if they have
occasional superimposed relapses, progressive
relapsing MS [1, 2]. Depending on the actual
diagnostic criteria, monosymptomatic forms of
MS have also been recognized and termed
clinically isolated syndromes [1].
Considering the clinical hallmarks of MS,
such as its chronic and unpredictable course that
usually begins in young adulthood, i.e., during
the most productive phase of life on an
individual, professional and societal level, the
social aspects of MS appear to be very important.
However, these aspects have been scarcely
studied so far. In fact, similar to other chronic
diseases, MS raises social issues beyond clinical
changes, causing physical, psychological and
social problems. Overall, the inter-relationship
between the disease and all these problems will
influence how the patient perceives their health
and quality of life (QoL).
Health-related quality of life (HRQoL),
defined as a multi-dimensional construct
that includes physical, mental and social
health [3], has been increasingly studied in
MS, since the wellbeing of patients involves
living and coping with a chronic neurological
condition and incorporates social aspects,
combining physical, mental and social health
[4, 5]. In addition, HRQoL is also a measure of
the effectiveness of interventions in health
care at the clinical practice level and in
planning public policies, supporting the view
that health is the most important domain of
QoL.
As far as we are aware, the first study of
HRQoL in MS was published in 1992, and since
2002 more than three-dozen articles have
appeared in the literature [4]. Overall, research
has focused on the relationship between the
clinical effects of the disease, such as disability,
pain, fatigue, psychological and cognitive
symptoms [5]. The methodology includes
case–control and cross-sectional studies, which
compare MS with other chronic diseases [6] or
with the general population [7–9] to analyze the
HRQoL of MS patients according to treatment
and different forms of the disease [10–14]. These
studies have demonstrated that MS patients
have worse QoL than the general population [8,
9], their disabilities are a predictor of HRQoL [7,
15], they have a high incidence of pain [10, 16–
21], and they suffer with more frequent
depressive symptoms [7, 12, 16, 22–28],
cognitive deterioration [11, 20, 21, 25–29] and
fatigue [13, 19, 24, 28, 30].
However, few studies have focused on the
relationship between patient social
characteristics and HRQoL [7, 9, 22, 23, 30–
32]. Studies that have analyzed the
relationships between the social characteristics
of MS patients and HRQoL [7, 9, 22, 30] have
frequently presented limited results, since they
only compare two or three social characteristics
[9, 11, 30, 33], and have often not reached
significance levels.
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This study aims to evaluate the association
between the social and clinical characteristics of
MS patients and their HRQoL, addressing an
issue scarcely discussed in the literature and
raising the need for different health care
professionals to pay more attention to these
aspects to improve QoL in MS.
MATERIALS AND METHODS
A cross-sectional study was conducted to
analyze the association between the social
characteristics and HRQoL of patients with
MS. The research protocol was submitted and
approved by the Hospital Sa˜o Joa˜o (Oporto,
Portugal) Ethics Committee. This article does
not contain any studies with human or animal
subjects performed by any of the authors.
Patients
The sample was composed of 150 consecutive
patients attending the MS Outpatient Clinic of
Hospital Sa˜o Joa˜o, with an MS diagnosis
confirmed by the neurologists according to the
McDonald criteria [1]. Written informed
consent was obtained from each patient.
Illiterate patients and those with physical and
mental disabilities prior to MS were excluded.
Procedures
An interview was conducted using a specifically
designed questionnaire to collect socio-
demographic data (gender, age, marital status,
education level, occupation, employment status
and number of persons in the household) and
assess patient QoL. MS parameters (clinical
course, duration and disability) were collected
from medical records. Disability was assessed
using the Expanded Disability Status Scale
(EDSS).
All interviews were conducted by David C.
Costa with the clinical assistance of Maria J. Sa´.
Instruments
The EDSS [34] is the most widely used scale for
assessing disability in MS patients. It consists of
an ordinal scale with a range of values from 0
(corresponding to a normal neurological
examination) to 10 (death by MS). The EDSS
has 0.5 increments between units, except for
the range between 0 and 1. Scores from 0 to 3.5
are considered to represent mild disability,
scores of between 4.0 and 6.0 represent
moderate disability, while scores of C6.5
represent severe disability [29].
HRQoL was assessed using the Health Status
Questionnaire (SF-36v2) [35, 36], which is the
Portuguese version of the Medical Outcome
Study 36-Item Health Survey Short Form (SF-36)
[37]. This scale was adapted and validated for
the Portuguese population, assessing HRQoL in
two dimensions:
• Physical dimension [physical function (PF),
physical role (PR), body pain (BP), general
health (GH)];
• Mental dimension [vitality (VT), social
function (SF), role limitations—emotional
(ER), mental health (MH)].
The SF-36 scoring system covers all items and
ranges from 0 to 100, so that a higher score
represents better QoL [37].
Statistical Analysis
Statistical analysis was performed using the
Statistics Package for Social Sciences (version
19). Mann–Whitney U and Kruskal–Wallis
H non-parametric tests, with a confidence
interval (CI) set at 95%, for comparing the
results of socio-demographic variables and the
Neurol Ther (2013) 2:43–56 45
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clinical parameters of MS with HRQoL were
used.
RESULTS
Socio-demographic characteristics and the
clinical parameters of MS patients are
presented in Table 1. The mean age of the
sample population was 41.7 years; 70.7% were
females with a female:male ratio of 2.4. Sixty-six
percent of the patients were married and 11.3%
were divorced, while 6.0% were widowed.
Regarding education level, the majority
(38.7%) had finished primary education and
32% had completed secondary grade education.
However, 12.7% of patients did not have a
minimum education level. The majority of
patients were non-qualified workers (52.7%),
while 47.3% were qualified workers with
technical skills. The majority of the patients
(44.0%) were retired from work and 35% were
currently employed. Thirty-eight percent of the
patients lived in households with three persons
and 32.0% lived in households with C4 persons.
With regard to MS course, the RR, PP and SP
forms of the disease were found in 85.3, 4.0, and
10.7% of cases, respectively. Participants had an
average MS duration of 9.1 years [standard
deviation (SD) 6.4, 95% CI 1–25], and the
average disability score was 2.5 (SD 2.4, 95%
CI 0–99).
Socio-demographic characteristics and the
physical health aspects of HRQoL comparisons
are presented in Table 2. No statistically
significant differences were found between
gender and any domain of the HRQoL in
relation to physical health. Younger patients
presented with higher scores in PF, PR, BP and
GH variables than older patients, and these
differences were statistically significant.
Regarding the association between marital
Table 1 Socio-demographic and clinical characteristics
Characteristics and
parameters of MS
n % Mean (–SD;
range)









Divorced or separated 17 11.3
Education level
Less than basic school 19 12.7
Basic school 58 38.7
Secondary school 48 32.0
Higher education 25 16.7
Occupation
Qualiﬁed worker 71 47.3








Number of persons in the household
2 or less 45 30.0
3 57 38.0
4 or more 48 32.0
Clinical course of MS
Relapsing remitting 128 85,3
Primary progressive 6 4.0
Secondary progressive 16 10.7
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status and HRQoL, single and married patients
showed better scores than widowed and
divorced/separated patients, but these
differences were not statistically significant.
Marital status was statistically significantly
associated with PF and GH. In all other
domains, no differences were observed
between marital status and PR or BP. When
education level was assessed in relation to PF,
PR, BP and GH, statistically significant
differences were observed. Patients with a
higher education level had significantly higher
scores in these variables than patients with a
lower education level. Qualified workers had
higher scores than non-qualified workers and
this difference was statistically significant for
PF, PR and BP. Patient employment status
showed statistically significant differences in
relation to all dimensions of physical health.
Employed patients presented with higher scores
than others (unemployed, retired and student/
housewife/inactive) and this difference was also
statistically significant.
Table 3 presents socio-demographic
characteristics in relation to mental health
HRQoL dimensions. No statistically significant
differences were found between gender and any
mental health domain of HRQoL. Age group,
education level and employment status differed
significantly among the groups in relation to
VT, SF, ER and MH. Young, employed, high
education patients had higher scores than old,
unemployed, low education, retired, student or
housewife patients. The scores referred were
statistically significant for VT, SF, ER and MH.
Table 4 displays the results of comparisons
between MS parameters and HRQoL
dimensions. There was a statistically
significant association between MS duration
and PR. However, no statistical significance
was observed for PF, BP and GH. Nevertheless,
patients with MS for less than 10 years
presented with better scores across all
dimensions of the HRQoL. MS clinical course
was statistically associated with PF, PR and GH.
Patients who presented with the RR form of MS
had better scores in all HRQoL domains than
those with the PP and SP forms, and these
differences were statistically significant for PF,
PR and GH. When we considered mild,
moderate and severe levels of disability and
HRQoL variables, we identified a statistically
significant association with all dimensions,
except BP. Patients with a mild disability level
had better HRQoL scores than those with
moderate and severe disability. These
differences were statistically significant for PF,
PR and GH.
Comparing the results of MS with HRQoL
dimensions and SF-36 mental health scores
(Table 5), the duration of MS was statistically
associated with VT, SF and ER. Patients who had
MS for less than 10 years presented with better
scores than those with longstanding MS across
all dimensions of the HRQoL.
The clinical course of MS was statistically
associated with SF and ER. Patients who
presented with the RR form had better scores




n % Mean (–SD;
range)






EDSS 150 2.5 (2.4; 0–9)
EDSS Expanded Disability Status Scale, MS multiple
sclerosis, SD standard deviation
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and these differences were statistically
significant for SF and ER. Mild, moderate and
severe disability levels were statistically
associated with the VT, SF and ER domains of
the HRQoL. Patients with a mild level of
disability had slightly better HRQoL scores
than those with moderate and severe
disability; these differences were statistically
significant for VT, SF and ER.
DISCUSSION
Many studies in recent years have explored QoL
in MS [6]; however, this topic has been of growing
interest among researchers who have analyzed
QoL in several settings [32]. The present study
analyzed the social characteristics associated
with the physical and emotional dimensions of
the HRQoL in MS patients. With the exception of
age and gender, few of the previous studies have
analyzed socio-demographic characteristics,
such as marital status, education level,
occupation, employment status and the
number of persons in the household, using
bivariate analysis [9, 11, 30, 33]. Our study was
innovative because it proposed a broader analysis
of the relationship between socio-demographic
characteristics and HRQoL dimensions.
Despite the different social contexts of the
studies available in the literature, the socio-
demographic characteristics of our sample were
identical to those reported elsewhere with
regard to age and gender, since the average
age of our patients was similar to that reported
in other studies, e.g., 48.0 years [11, 16] and
38.9 years [17].
The bivariate analysis performed did not find
statistically significant relationships between
gender and all dimensions of HRQoL, as was
reported in other studies [9, 30, 33].
Patients in lower age groups (B40 years) had
better results in all SF-36 subscales in our study.
This was consistent with the results of Gottberg
and colleagues [9] who identified that age was
negatively correlated with all HRQoL
dimensions.
We found that among our sample, 66% of
MS patients were married and only one other
study had analyzed marital status in relation to
HRQoL [9]. As in our study, the authors of this
other study also observed that there was no
statistically significant relationship between
being single and HRQoL measures. However,
our study found a statistically significant
relationship between marital status and PF and
GH. We believe it necessary to reapply this
analysis in light of sociological literature stating
that married persons have better HRQoL than
single persons [31].
We found that education level was
associated with all SF-36 subscales. Patients
who had higher levels achieved better scores
than those with lower education levels. These
data are similar to those of other studies, such as
the one by Gottberg and collaborators [9].
Turpin et al. [22] showed that 28.5% of MS
patients lacked an occupation; however, none
of the analyzed studies took into account
occupation in relation to HRQoL. In our
study, better educationally qualified patients
presented with better scores on all SF-36
subscales than those with a lower education
level. These differences were statistically
significant in the PF, PR, BP and SF subscales.
The employment status of MS patients
presents a statistically significant relationship
with all HRQoL dimensions. Employed patients
had better scores than those who were
unemployed, retired and student/housewife/
inactive, and these differences were
statistically significant. These results are
similar to those obtained by Gottberg et al. [9],
Shawryn et al. [11], Aronson [30] and Pluta-
Fuerst et al. [33]. These other studies clearly
48 Neurol Ther (2013) 2:43–56
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determined that patients with better
employment status had better HRQoL
measures than the unemployed or those who
were not in paid employment. Although
unemployment could not be exclusively
associated with MS, which is also associated
with a country’s economic structure and
occupation policy for the socially
disadvantaged, this finding requires further
analysis.
Household size was not statistically related to
HRQoL measures. Patients who lived in larger
households had better results than those living in
smaller households, as expected, but this
difference was not statistically significant. As a
matter of fact, the sociological literature [31]
indicates that the probability of getting help is
greater in larger households. However, this
relationship was not shown to be true according
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n.s. not signiﬁcant, SF-36 short form 36, SD standard deviation
a,b,c Homogeneous groups according to the Mann–Whitney test, to 95% conﬁdence interval
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Female (n = 106) 42.9
(±25.6)
68.9 (±28.4) 61.7 (±32.9) 55.1
(±24.3)
Male (n = 44) 50.4
(±25.4)






































Married (n = 99) 44.1
(±26.8)
69.6 (±28.7) 60.4 (±33.2) 55.4
(±25.7)
Single (n = 25) 56.3
(±22.8)
76.0 (±25.7) 75.7 (±26.0) 62.9
(±24.3)
Widowed (n = 9) 31.9
(±16.4)
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MS parameters in our study referred to the
duration and type of MS, and MS-associated
disability. Our results were similar to those in
the literature [3, 9, 21, 23] in which the
relationship between these parameters and
HRQoL was analyzed. The duration of MS was
significantly associated with PR and all SF-36
mental health dimensions, such as VT, SF and
ER. Patients with a shorter MS duration had
higher scores on all HRQoL dimensions than
those with a longer MS duration. These results
are consistent with those of other studies [9,
16], highlighting the negative correlation
between all HRQoL domains and MS duration
when it lasts for more than 10 years [5, 11, 33].
The clinical course of MS was statistically
related to PF, PR, GH, SF and ER. The score
obtained by MS patients with the RR form of the
disease was higher than the score obtained by
MS patients with other forms of the disease (PP
and SP). These results are similar to those














Qualiﬁed worker (n = 71) 47.8
(±25.6)













































Number of persons in the household
2 or less (n = 45) 45.0
(±28.7)
69.2 (±31.0) 63.5 (±36.3) 58.7
(±25.2)
3 (n = 57) 43.4
(±22.5)
71.9 (±28.7) 57.6 (±31.4) 55.8
(±21.5)
4 or more (n = 48) 47.3
(±26.7)
n.s. 69.3 (±27.4) n.s. 67.0 (±31.6) n.s. 54.7
(±27.4)
n.s.
n.s. not signiﬁcant, SF-36 short form 36, SD standard deviation
a,b,c Homogeneous groups according to the Mann–Whitney test, to 95% conﬁdence interval
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However, they differed on the results of a study
by Aronson, which highlighted the relationship
between RR clinical form and decrease in
HRQoL. In this study, the author compares
clinical forms with HRQoL as a whole [31]. In
our study, we compare the clinical forms of MS
with each dimension of HRQoL.
MS patients with high disability scores (EDSS
4–6 and C6.5) had lower HRQoL levels than
those with lower scores (EDSS 0–3.5). The level
of disability was statistically associated with
HRQoL, particularly PF, PR, GH, VT, SF and ER.
Patients with mild disability had higher HRQoL
scores than those with severe levels of disability.
These differences were statistically significant
for these subscales. These results are similar to
those of the majority of studies reviewed, as it
indicates that disability is a predictor of HRQoL
[9, 15, 33].
Although there are scales that are more
specific to the MS setting, such as the MSQoL-
54 [38], the generic SF-36 is the scale used
mostly in studies of HRQoL in MS patients [7].
In addition, the only scale adapted and
validated for a Portuguese population is the
SF-36 [35, 36].
Finally, the authors could not identify
publications entirely devoted to the
comparison between the socio-demographic
characteristics of MS patients and HRQoL
Table 4 Analysis of clinical characteristics with SF-36 (Physical Health)
Physical
function
Physical role Body pain General
health
Mean (–SD) P Mean (–SD) P Mean
(–SD)
P Mean (–SD) P
MS duration
10 years or less (n = 95) 59.7 (±34.1) 63.0 (±34.1) 67.8 (±34.1) 44.2 (±22.6)
More than 10 years
(n = 55)




60.9 (±31.9)a 62.6 (±32.2)a 64.9 (±32.2) 44.4 (±20.5)a
Primary progressive
(n = 6)
16.7 (±29.6)b 39.6 (±26.4)a 54.0 (±26.4) 26.2 (±21.7)b
Secondary progressive
(n = 16)
33.4 (±32.6)b 0.000 32.0
(±27.9)b
0.001 65.4 (±27.9) n.s 36.0 (±16.9)b 0.015
EDSS
Light (n = 103) 66.2 (±31.0)a 67.5 (±30.6)a 67.0 (±30.6) 46.7 (±21.0)a
Moderate (n = 29) 44.7 (±26.5)b 39.7
(±27.3)b
57.2 (±27.3) 36.9 (±16.5)b
Severe (n = 18) 17.8 (±26.5)c 0.000 36.8
(±33.1)b
0.000 61.9 (±33.1) n.s 29.8 (±16.1)b 0.001
EDSS Expanded Disability Status Scale, MS multiple sclerosis, n.s. not signiﬁcant, SD standard deviation
a,b,c Homogeneous groups according to the Mann–Whitney test, to 95% conﬁdence interval
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measures. Some studies only analyzed one or
other social characteristic Hrolf, because they
are neglected relative to other factors that affect
the HRQoL of MS patients.
CONCLUSIONS
Our study illustrates the social characteristics of
MS patients that impart a significant impact on
their perception of HRQoL. The HRQoL concept is
known to be multifactorial. Younger MS patients,
those who have higher education levels, those
who are employed and have a lower degree of MS
progression and lower disability reported greater
QoL than others. These results may contribute to
more detailed knowledge concerning the
importance of social characteristics in MS
patients in relation to HRQoL to provide
improved health care planning.
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P Mean (–SD) P Mean (–SD) P Mean (–SD) P
MS duration
10 years or less (n = 95) 48.8
(±26.9)
73.7 (±28.7) 66.9 (±34.7) 58.3 (±24.6)




















n.s 65.6 (±20.2)b 0.041 39.1 (±28.5)b 0.009 51.6 (±16.3) n.s.
EDSS
Light (n = 103) 49.4
(±26.4)a
73.4 (±28.8)a 68.6 (±30.3)a 58.6 (±25.8)
Moderate (n = 29) 36.2
(±21.8)b
70.3 (±26.0)b 52.3 (±35.1)b 53.9 (±22.6)
Severe (n = 18) 35.1
(±21.3)b
0.007 52.1 (±28.2)b 0.009 43.1 (±34.8)b 0.004 47.1 (±17.4) n.s.
EDSS Expanded Disability Status Scale, MS multiple sclerosis, n.s. not signiﬁcant, SD standard deviation
a,b Homogeneous groups according to the Mann–Whitney test, to 95% conﬁdence interval
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